Ignite Creation Date:
2024-05-06 @ 8:25 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02734485
Status:
COMPLETED
Last Update Posted:
2023-06-26
First Post:
2016-03-31
Brief Title:
Deep TMS for the Treatment of Patients With Parkinsons Disease and Progressive Supranuclear Palsy
Sponsor:
IRCCS San Raffaele Roma
Organization:
IRCCS San Raffaele Roma
Study Overview
Official Title:
The Use of Deep TMS for the Treatment and Rehabilitation of Patients With Parkinsons Disease and Progressive Supranuclear Palsy
Status:
COMPLETED
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DeepTMSPARK
Brief Summary:
Background Progressive supranuclear palsy PSP is a rare neuro-degenerative disease counted among atypical parkinsonism AP Medical treatment and rehabilitation are extremely limited in AP therefore it would be very useful to find new ways to improve motor and non motor symptoms in PSP The Brainway Deep Transcranial magnetic stimulation DTMS is a new technology of TMS using a particular coil ie H-coil able to stimulate deeper regions of the brain Only few studies in literature have evaluated the efficacy of DTMS in Parkinsons Disease and parkinsonism in particular in PSP patients a case report showed an improvement in language
Detailed Description:
Materials and Methods This study was a pilot randomized cross-over double blind trial It was designed to evaluate the efficacy of Deep TMS in terms of recovery of motor functions freezing of gait and cognitive decline in patients with PSP Nineteen subject underwent 14 session of high frequency DTMS over a 4 weeks period The target were the left Broca and dorsolateral prefrontal cortex
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None